Skip to main content

Diasome Pharmaceuticals

Cleveland, United States

Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.

$9.0M raised
Jun 2023
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Diasome Pharmaceuticals

How much funding has Diasome Pharmaceuticals raised?
Diasome Pharmaceuticals has raised $9.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2023.
Who are Diasome Pharmaceuticals's investors?
Diasome Pharmaceuticals's investors include Medicxi, JDRF T1D Fund, Quaker BioVentures, Devon Park BioVentures, McDonald Partners.
Where is Diasome Pharmaceuticals headquartered?
Diasome Pharmaceuticals is headquartered in Cleveland, United States.
What does Diasome Pharmaceuticals do?
Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.
What stage is Diasome Pharmaceuticals at?
Diasome Pharmaceuticals is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Diasome Pharmaceuticals — Funding & Investors." VCBacked, June 30, 2023, https://www.vcbacked.co/company/diasome-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2023). Diasome Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/diasome-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Diasome Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/diasome-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .